Literature DB >> 10713000

Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: the impact of immigration.

J Gilad1, A Borer, K Riesenberg, N Peled, F Schlaeffer.   

Abstract

STUDY
OBJECTIVES: To assess the incidence of tuberculosis in the native and immigrant populations of southern Israel in the period between 1992 and 1997, and to study the prevalence of drug resistance overall and among these subpopulations in the region in order to create guidelines for empirical antituberculous treatment in this region.
DESIGN: A retrospective population-based study.
SETTING: The southern district of the country and its tertiary-care hospital. PATIENTS: All new culture-proven tuberculosis cases diagnosed in adults residing in the Negev region during the study period. Patients were classified into four groups according to ethnic origin and immigration date.
RESULTS: During the study period, 249 new cases involving 249 patients were recorded. Immigrants from the former Soviet Union (IFSU) were significantly younger and of male gender, and the incidence among this group rose sharply. IFSU had higher rates of resistance to any drug or drug combination. Isoniazid resistance rates were 16% overall and 32% among IFSU. Resistance to any drug was observed in 29% overall and 50% of isolates among IFSU. Multidrug-resistant tuberculosis was observed in 8.5% and 17%, respectively.
CONCLUSIONS: The population of southern Israel carries very high rates of drug-resistant tuberculosis, mandating quadruple empiric treatment. IFSU should be regarded as having multidrug-resistant tuberculosis until proven otherwise, and empiric therapy with at least five drugs should be considered. This report demonstrates the influence of immigration on the incidence of tuberculosis, and the great value of local surveillance of population-specific resistance rates in an immigrant society, in order to optimize drug treatment and prevent the dissemination of resistant strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713000     DOI: 10.1378/chest.117.3.738

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Outcome of hospitalized MDR-TB patients: Israel 2000-2005.

Authors:  D Bendayan; A Hendler; V Polansky; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-23       Impact factor: 3.267

2.  Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China.

Authors:  W Wang; J Wang; Q Zhao; N D Darling; M Yu; B Zhou; B Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-21       Impact factor: 3.267

Review 3.  The epidemiology of tuberculosis in Europe.

Authors:  Tony Walls; Delane Shingadia
Journal:  Arch Dis Child       Date:  2007-08       Impact factor: 3.791

Review 4.  Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.

Authors:  A Faustini; A J Hall; C A Perucci
Journal:  Thorax       Date:  2005-10-27       Impact factor: 9.139

5.  Early diagnosis of extrapulmonary tuberculosis by a new procedure combining broth culture and PCR.

Authors:  Latifa Noussair; Frédéric Bert; Véronique Leflon-Guibout; Nadine Gayet; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

6.  Nomogram for individualized prediction of incident multidrug-resistant tuberculosis after completing pulmonary tuberculosis treatment.

Authors:  Qinglin Cheng; Gang Zhao; Xuchu Wang; Le Wang; Min Lu; Qingchun Li; Yifei Wu; Yinyan Huang; Qingjun Jia; Li Xie
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.